Obesity drug semaglutide fails to slow Alzheimer’s
Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer’s – despite initial hopes that it might help against dementia. Researchers began two large trials involving more than 3,800 people after reports the medicine was having an impact in the real world. But the studies showed…


